More interestingly, alteration in Rcan2 levels was previously found to be correlated with the development of tumor [31], whereas Rcan2 is also known to regulate the obesity progression via a mechanism-independent of leptin signaling [32, 33]. This evidence concerns the gene RCAN2 and obesity due to melanocortin 4 receptor deficiency.